Oncology

Gastroenteropancreatic Neuroendocrine Tumors

Advertisment

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 ASCO-GI Cancers Symposium

conference reporter by Timothy J. Hobday, MD; Jonathan R. Strosberg, MD
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Gastroenteropancreatic Neuroendocrine Tumors presented at this year’s ASCO-GI Cancers Symposium.


VIEW THE TOPICS

 

  • Gastric Neuroendocrine Tumors: Updates, Perspectives, and Controversies
  • Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials
  • Potential Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
  • Repeat Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms
  • Surveillance After Complete Resection of Gastroenteropancreatic Neuroendocrine Tumors
  • Treating Midgut vs Non-Midgut GEP-NETs: Real-World Data

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

 

Timothy J. Hobday, MD

Associate Professor of Oncology
Education Chair, Division of Medical Oncology
Program Director, Hematology/Oncology Fellowship
Mayo Clinic College of Medicine and Science
Rochester, MN

Jonathan R. Strosberg, MD

Professor of Gastrointestinal Oncology
Section Head, Neuroendocrine Tumor Division
Chair, Gastrointestinal Department Research Program
Moffitt Cancer Center
Tampa, FL

Advertisment